Inactive Instrument

Highlights CHF Solutions Inc Nasdaq

Equities

US12542Q5080

Highlights

Unlock all the news: Be the first to know and act before the market!

Top Midday Gainers	05-07	MT
Nuwellis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-07	CI
Earnings Flash (NUWE) NUWELLIS Reports Q1 Revenue $1.9M, vs. Street Est of $2M	05-07	MT
Nuwellis, Inc. Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology	05-02	CI
Nuwellis, Inc. Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health	04-09	CI
Nuwellis, Inc. Announces Results from Two New Clinical Data Analyses from the AVOID-HF Trial, Which Demonstrate the Benefits of its Aquadex System in Reducing Heart Failure Readmissions at 30 Days	03-07	CI
Nuwellis, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	03-06	CI
Earnings Flash (NUWE) NUWELLIS Reports Q4 Revenue $2.6M	03-05	MT
Nuwellis, Inc. Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter	01-04	CI
Nuwellis, Inc. Announces New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring Foriatric Patients	11-28	CI
Nuwellis, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-07	CI
Earnings Flash (NUWE) NUWELLIS Reports Q3 Revenue $2.4M	11-07	MT
Nuwellis Provides Regulatory Update on Seastar Medical's Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under A Humanitarian Device Exemption	10/10/23	CI
Earnings Flash (NUWE) NUWELLIS Reports Q2 Revenue $2.1M, vs. Street Est of $2.19M	08/08/23	MT
Nuwellis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	08/08/23	CI
Nuwellis Signs Supply, Collaboration Agreement With DaVita for Aquadex Ultrafiltration Therapy Pilot Program	20/06/23	MT
Nuwellis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	09/05/23	CI
Earnings Flash (NUWE) NUWELLIS Reports Q1 Revenue $1.8M, vs. Street Est of $2.3M	09/05/23	MT
Nuwellis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01/03/23	CI
Nuwellis, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	01/03/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights CHF Solutions Inc Nasdaq

Equities

US12542Q5080

Highlights

Filters